Day: May 29, 2026

Lung cancer targeted therapy research is progressing in three significant ways. First, researchers are tackling treating lung cancer at earlier stages. “These drugs were initially developed and approved primarily for patients with metastatic lung cancers, meaning advanced cancers that had already spread to other areas,” explains Byers.